Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Treatment Period	STARTED	Saline	20
Treatment Period	STARTED	Eculizumab	40
Treatment Period	COMPLETED	Saline	19
Treatment Period	COMPLETED	Eculizumab	38
Treatment Period	NOT COMPLETED	Saline	1
Treatment Period	NOT COMPLETED	Eculizumab	2
Follow-Up Period	STARTED	Saline	19
Follow-Up Period	STARTED	Eculizumab	38
Follow-Up Period	COMPLETED	Saline	19
Follow-Up Period	COMPLETED	Eculizumab	38
Follow-Up Period	NOT COMPLETED	Saline	0
Follow-Up Period	NOT COMPLETED	Eculizumab	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00935883/flow